Mohammad Shaquiquzzaman
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Development, synthesis and preclinical evaluation of naringenin and its semi-synthetic derivatives in postmenopausal osteoporosis.
Journal: Natural product research
Published: October 16, 2025
Pharmacophore-guided review of EGFR-targeted anticancer drugs with gefitinib as a reference.
Journal: European journal of medicinal chemistry
Published: September 29, 2025
Computational study of chalcone-cyanopyrimidine hybrids as LSD1 inhibitors: Assessing the influence of FAD on binding affinity and inhibition.
Journal: Biochemistry and biophysics reports
Published: July 07, 2025
Anticancer activity of hydrazones in the last quinquennial period: A special emphasis on various enzyme targets and SAR.
Journal: European journal of medicinal chemistry
Published: July 05, 2025
Tranylcypromine-derived LSD1 inhibitors: Synthetic strategies, structure-activity relationships, and anticancer potential.
Journal: European journal of medicinal chemistry
Published: May 02, 2025
Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer.
Journal: Journal of biomolecular structure & dynamics
Published: March 10, 2025
Identification of Novel Leads as Antitubercular Agents that Target Mtb-DHFR by using Virtual Screening.
Journal: Current medicinal chemistry
Published: February 11, 2025
Mechanistic insights into novel cyano-pyrimidine pendant chalcone derivatives as LSD1 inhibitors by docking, ADMET, MM/GBSA, and molecular dynamics simulation.
Journal: Biochemistry and biophysics reports
Published: December 01, 2024
Osteogenic effect of alogliptin in chemical-induced bone loss: a tri-modal in silico, in vitro, and in vivo analysis.
Journal: The Journal of pharmacy and pharmacology
Published: February 22, 2024
Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling.
Journal: Bioorganic chemistry
Published: October 25, 2023
Synthesis and HDAC1 inhibitory activity of a novel series of coumarin-based amide derivatives for treatment of cancer.
Journal: Future medicinal chemistry
Published: September 21, 2023
Last Updated: 09/26/2026